Matthew Hawkins Sells 60,038 Shares of Waystar (NASDAQ:WAY) Stock

Waystar Holding Corp. (NASDAQ:WAYGet Free Report) CEO Matthew Hawkins sold 60,038 shares of the company’s stock in a transaction dated Thursday, August 13th. The stock was sold at an average price of $25.01, for a total transaction of $1,501,550.38. Following the transaction, the chief executive officer owned 1,835,081 shares of the company’s stock, valued at $45,895,375.81. This represents a 3.17% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Waystar Trading Down 1.2%

Shares of NASDAQ:WAY opened at $24.78 on Friday. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.36. The company’s 50-day moving average price is $21.62 and its 200 day moving average price is $22.78. The company has a market cap of $4.75 billion, a PE ratio of 35.40, a P/E/G ratio of 0.98 and a beta of 0.06. Waystar Holding Corp. has a fifty-two week low of $17.26 and a fifty-two week high of $41.47.

Waystar (NASDAQ:WAYGet Free Report) last posted its earnings results on Wednesday, July 29th. The company reported $0.43 EPS for the quarter, topping the consensus estimate of $0.40 by $0.03. The firm had revenue of $319.67 million during the quarter, compared to analysts’ expectations of $316.21 million. Waystar had a net margin of 11.18% and a return on equity of 7.03%. Waystar’s quarterly revenue was up 18.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.36 EPS. Sell-side analysts anticipate that Waystar Holding Corp. will post 1.47 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have weighed in on WAY. UBS Group cut their target price on Waystar from $37.00 to $33.00 and set a “buy” rating on the stock in a research note on Thursday, July 30th. Needham & Company LLC reissued a “buy” rating and issued a $33.00 price target on shares of Waystar in a research note on Thursday, July 30th. Barclays raised their price target on Waystar from $25.00 to $27.00 and gave the company an “overweight” rating in a report on Friday, August 7th. Wells Fargo & Company reduced their price objective on shares of Waystar from $36.00 to $33.00 and set an “overweight” rating for the company in a report on Thursday, July 30th. Finally, Wall Street Zen lowered shares of Waystar from a “buy” rating to a “hold” rating in a research report on Sunday, May 24th. Three equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $35.00.

View Our Latest Stock Report on Waystar

Hedge Funds Weigh In On Waystar

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Royal Bank of Canada increased its position in shares of Waystar by 11.3% during the 1st quarter. Royal Bank of Canada now owns 21,609 shares of the company’s stock valued at $808,000 after purchasing an additional 2,195 shares during the period. AQR Capital Management LLC acquired a new stake in shares of Waystar in the first quarter valued at $203,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Waystar by 91.1% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 46,911 shares of the company’s stock valued at $1,753,000 after buying an additional 22,364 shares in the last quarter. NewEdge Advisors LLC bought a new position in Waystar during the first quarter valued at about $234,000. Finally, Goldman Sachs Group Inc. boosted its stake in Waystar by 13.4% during the first quarter. Goldman Sachs Group Inc. now owns 747,268 shares of the company’s stock valued at $27,918,000 after buying an additional 88,256 shares in the last quarter.

About Waystar

(Get Free Report)

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.

Recommended Stories

Insider Buying and Selling by Quarter for Waystar (NASDAQ:WAY)

Receive News & Ratings for Waystar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waystar and related companies with MarketBeat.com's FREE daily email newsletter.